Friday, October 30, 2015

Isis Pharmaceuticals begins ISIS-FXI Rx Phase 2 study in patients with ESRD on hemodialysis

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in…
from Total Knee Replacement Recovery http://totalkneereplacementrecovery.tumblr.com/post/132206713069

from Tumblr http://wendyjborst.tumblr.com/post/132206768425


No comments:

Post a Comment